Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Bioactive Compounds

Bioactive Compounds

Items 7481-7490 of 12127

Page
per page
  1. Etravirine (TMC125)
    B2224 Etravirine (TMC125)
    Target: Reverse Transcriptases
    Summary: Reverse transcriptase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.35 mg/mL
  2. Rac GTPase fragment
    A1086 Rac GTPase fragment
    Summary: Fragment of small signaling G proteins
      ≥101.9 mg/mL
  3. survivin (baculoviral IAP repeat-containing protein 5) (21-28)
    A1092 survivin (baculoviral IAP repeat-containing protein 5) (21-28)
    Summary: Cancer Biology Peptides
      ≥105.2 mg/mL
  4. Vilazodone
    A3918 Vilazodone
    Summary: Combined SSRI and 5-HT1A receptor partial agonist
      ≥43.67 mg/mL
  5. CDK9-IN-10
    BA3838 CDK9-IN-10
    Summary: CDK9-IN-10 is a potent inhibitor.
  6. Fmoc-Cpg-OH
    BA9322 Fmoc-Cpg-OH
    Summary: A glycine derivative.
  7. (±)-Carnitine-d9 chloride
    SL1024 (±)-Carnitine-d9 chloride
    Summary: A stable isotope deuterated compound of Carnitine chloride
  8. PD153035 hydrochloride
    A8199 PD153035 hydrochloride
     1 Citation
    Target: EGFR
    Summary: Potent EGFR inhibitor
      insoluble in EtOH; insoluble in H2O; ≥3.97 mg/mL
  9. LY2784544
    A4147 LY2784544
    Target: Aurora Kinases|FLT3|VEGFR|FGFR|Trk Receptors|JAK|ALK|TYK2|MUSK|MAP3K
    Summary: JAK2 inhibitor,highly potent and selective
      ≥23.5 mg/mL
  10. ENMD-2076 L-(+)-Tartaric acid
    A4129 ENMD-2076 L-(+)-Tartaric acid
    Summary: Aurora kinases inhibitor
      insoluble in EtOH; ≥175.8 mg/mL

Items 7481-7490 of 12127

Page
per page